We devoted ourselves to research and development of siRNA, an internationally leading precision medical product and provides targeted gene-based drugs and immunotherapeutic drugs for cancer treatment. At the same time, we develop efficient low-toxic nanopeptide drug delivery systems for targeted treatment of multiple diseases.